(Q45330394)

13 December 2017

title

Reasons for underuse of recommended therapies for colorectal and lung cancer in the Veterans Health Administration (English)

1 reference

13 December 2017

0 references

1 reference

2

Nancy L Keating

1 reference

13 December 2017

5

Barbara J McNeil

1 reference

13 December 2017

1

Mary Beth Landrum

1 reference

13 December 2017

4

Samuel R Bozeman

1 reference

13 December 2017

Elizabeth B Lamont

3

1 reference

13 December 2017

language of work or name

English

0 references

publication date

9 November 2011

1 reference

13 December 2017

1 reference

13 December 2017

volume

118

1 reference

13 December 2017

issue

13

1 reference

13 December 2017

page(s)

3345-3355

1 reference

Are we finally winning the war on cancer?

13 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Racial differences in the treatment of early-stage lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Age and adjuvant chemotherapy use after surgery for stage III colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Do increases in the market share of managed care influence quality of cancer care in the fee-for-service sector?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Receipt of recommended therapy by patients with advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Quality of nonmetastatic colorectal cancer care in the Department of Veterans Affairs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Quality of care for older patients with cancer in the Veterans Health Administration versus the private sector: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Adjuvant chemotherapy for stage III colon cancer: do physicians agree about the importance of patient age and comorbidity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Variations in surgeon treatment recommendations for lobectomy in early-stage non-small-cell lung cancer by patient age and comorbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Explaining black-white differences in receipt of recommended colon cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

The effect of race on invasive staging and surgery in non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Residual treatment disparities after oncology referral for rectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Stage III colon cancers: why adjuvant chemotherapy is not offered to elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Evaluation of the causes for racial disparity in surgical treatment of early stage lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Racial Differences Pertaining to a Belief about Lung Cancer Surgery: Results of a Multicenter Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Factors associated with decisions to undergo surgery among patients with newly diagnosed early-stage lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Racial differences in doctors' information-giving and patients' participation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Use of SEER-Medicare data for measuring cancer surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Construct validity of medicare chemotherapy claims: the case of 5FU.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Studying radiation therapy using SEER-Medicare-linked data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Adjuvant chemotherapy use and adverse events among older patients with stage III colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

Racial differences in trust and lung cancer patients' perceptions of physician communication

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

7 January 2021

Colon cancer. Clinical practice guidelines in oncology.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

7 January 2021

Rectal cancer. Clinical practice guidelines in oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

7 January 2021

Non-small cell lung cancer clinical practice guidelines in oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.26628

7 January 2021

Identifiers

DOI

10.1002/CNCR.26628

1 reference

13 December 2017

1 reference